at research and development within a newly established oligonucleotide facility. Depending on experience... this exciting and challenging role you will assist in expanding the nucleotide and oligonucleotide synthesis capabilities aimed...
Oxford Nanopore Technologiesof biomolecules such as therapeutic proteins, oligonucleotides & glycans, vaccines and vectors for gene therapy. As an R&D Scientist... experience) Experience developing methods in at least two (preferably more) of the following areas: Oligonucleotide analysis...
Agilent Technologiesdevelopment and validation experience Experience of working with large molecules and proteins. Experience in Oligonucleotide... and able to build rapport, quickly and effectively ABOUT THE OPPORTUNITY Key activities: Scientist working across a vast...
Intertekdevelopment and validation experience Experience of working with large molecules and proteins. Experience in Oligonucleotide... and able to build rapport, quickly and effectively ABOUT THE OPPORTUNITY Key activities: Scientist working across a vast...
Intertekexpertise in partnership with innovative businesses to discover and test viable ways of delivering oligonucleotide therapies..., anchoring the oligonucleotide therapy industry in the UK for many years to come. The NATA will focus on bringing together key...
MRC NATAand test viable ways of delivering oligonucleotide therapies, anchoring the oligonucleotide therapy industry in the UK for many... collaborative R&D activity with focused support to tackle significant barriers facing oligonucleotide therapy delivery to key organs...
NATAand optimising the experimental work plan and scientific process; Orchestrating the development of cutting-edge oligonucleotide... memory cells to tolerogenic cells. The company is now seeking a scientist with expertise in immunology and T cell biology...
Deep Science Venturesscientist to work on a collaborative project between NATA and University College London (UCL). The project aims to develop... personalized antisense oligonucleotide (ASO) therapy for beta-propeller protein-associated neurodegeneration (BPAN), a rare early...
MRC NATAall stages of early company growth, with a focus on tumour biology, immunology and pre-clinical development. In addition... predictability. In addition, the development of resistance mechanisms, such as enhanced immune suppression, is frequent, as a result...
Deep Science Ventures